Sumampong, Justine Kay .

HRN: 28-13-34  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2026
CO-AMOXICLAV 625MG (TAB)
01/18/2026
01/25/2026
ORAL
625mg
BID
S/P NSD With Repair; Thinly MSAF
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines